---
title: "Psilocybin (COMP360) in Treatment-resistant depression: Current treatment options and standard of care"
description: "Formulary evidence on Psilocybin (COMP360) in Treatment-resistant depression: Current treatment options and standard of care. Covers Antidepressant optimization, switching, and combination; Second-generation antipsychotic augmentation; Lithium and thyroid hormone augmentation; Psychotherapy; Esketamine and ketamine; Repetitive transcranial magnetic stimulation; 3 further headings. 113 evidence topics quoted from 62 sources."
canonical: "https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description/current-treatment-options-and-standard-of-care"
published: "2026-11-18T10:42:20-05:00"
modified: "2026-11-18T10:42:20-05:00"
---

# Psilocybin (COMP360) in Treatment-resistant depression: Current treatment options and standard of care

<a id="heading-2.2.2.1"></a>

## 2.2.2.1 Current Treatment Options and Standard of Care

- [Antidepressant optimization, switching, and combination](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description/antidepressant-optimization-switching-and-combination)

- [Second-generation antipsychotic augmentation](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description/second-generation-antipsychotic-augmentation)

- [Lithium and thyroid hormone augmentation](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description/lithium-and-thyroid-hormone-augmentation)

- [Psychotherapy](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description/psychotherapy)

- [Esketamine and ketamine](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description/esketamine-and-ketamine)

- [Repetitive transcranial magnetic stimulation](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description/repetitive-transcranial-magnetic-stimulation)

- [Electroconvulsive therapy](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description/electroconvulsive-therapy)

- [Vagus nerve stimulation and other neuromodulation](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description/vagus-nerve-stimulation-and-other-neuromodulation)

- [Limitations of current therapies](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description/limitations-of-current-therapies)

## Related pages
- [Psilocybin (COMP360): Treatment-resistant depression](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression) · [Markdown](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression.md)
- [Psilocybin (COMP360) in Treatment-resistant depression: Terms and abbreviations](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/terms-and-abbreviations.md)
- [Psilocybin (COMP360): Treatment-resistant depression](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/executive-summary) · [Markdown](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/executive-summary.md)
- [Psilocybin (COMP360) in Treatment-resistant depression: Product information and disease description](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/product-information-and-disease-description.md)
- [Psilocybin (COMP360) in Treatment-resistant depression: Clinical evidence](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/clinical-evidence.md)
- [Psilocybin (COMP360) in Treatment-resistant depression: Economic information and modeling report](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/economics) · [Markdown](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/economics.md)
- [Psilocybin (COMP360) in Treatment-resistant depression: References](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/references) · [Markdown](https://www.evicenter.com/drugs/psilocybin--treatment-resistant-depression/references.md)
